FDA Inspection
Chengdu Shengnuo Biopharm Co LtdChengdu Shengnuo Biopharm Co Ltd – FDA Inspection, Sep 8, 2023
Record Details
This FDA Inspection record concerns Chengdu Shengnuo Biopharm Co Ltd, with an inspection on September 8, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 9c07302f-5743-4fd1-8da4-72f5e26f2e72
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219460
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Chengdu Shengnuo Biopharm Co Ltd
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 27, 2026 | Not classified | Office of Inspections and Investigations | |
| June 10, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 9, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Chengdu Shengnuo Biopharm Co Ltd
- FDA Inspection 1334998 - 2026-08-27
- FDA Inspection 978495 - 2016-06-10
- FDA Inspection 924616 - 2015-04-09
- FDA Inspection 784098 - 2012-05-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.